Literature DB >> 7220575

Pharmacological profile of a new antilipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) (1) II - Antilipolytic and blood lipid lowering activity.

P P Lovisolo, G Briatico-Vangosa, G Orsini, R Ronchi, R Angelucci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7220575     DOI: 10.1016/s0031-6989(81)80017-3

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


× No keyword cloud information.
  2 in total

1.  Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination.

Authors:  H Gylling; H Vanhanen; T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Acipimox inhibits human carbonic anhydrases.

Authors:  Mattia Mori; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.